Rare Tumours SACT regimens:
Whilst every effort is made to ensure the accuracy of the information in a given regimen it cannot be guaranteed that the regimen is fully up to date, because of the dynamic nature of cancer treatment. Check the regimen details for the specific indication the regimen may be used / funded in. See our disclaimer.
Adrenal
Carcinoid
Neuroendocrine
- Capecitabine (1000) – update requires CAG approval
- Carboplatin Etoposide
- Cisplatin Etoposide
- Everolimus
- Irinotecan Modified de Gramont (FolFIri) (local funding)
- Steptozocin Capecitabine
- Streptozocin Cisplatin Fluorouracil (FCiST)
- Steptozocin Modified de Gramont
- Sunitinib
- Temozolomide Capecitabine
Parathyroid
Penile
Thymoma
- Cisplatin Etoposide
- Cyclophosphamide Vincristine Dacarbazine (CVD)
- Doxorubicin Cisplatin Cyclophosphamide (CAP)
- Doxorubicin Cisplatin Vincristine Cyclophosphamide (ADOC)
Thyroid
Carcinoma of unknown primary (CUP)
Cisplatin hydration
SACT regimens written by S Coutts
For further information please contact us using our contact us page.[/vc_column_text]